Xylometazoline

Xylometazoline

SCHEMBL34087

Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2C

The experimentally established mechanism targets of Xylometazoline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 7/20 1.00
ADRA2B known ✓ P18089 6/20 1.00
ADRA2C known ✓ P18825 6/20 1.00
ADRA1D known ✓ P25100 5/20 1.00
ADRA1A known ✓ P35348 5/20 1.00
ADRA1B known ✓ P35368 5/20 1.00
HTR1D P28221 12/20 1.00
HTR1B P28222 10/20 1.00
HTR1A P08908 4/20 1.00
LMNA P02545 3/20 1.00
CYP2D6 P10635 3/20 1.00
TSHR P16473 3/20 1.00
CHRM2 P08172 2/20 1.00
CHRM1 P11229 2/20 1.00
HTR2A P28223 2/20 1.00
HTR2C P28335 2/20 1.00
DRD3 P35462 2/20 1.00
HTR2B P41595 2/20 1.00
TP53 P04637 1/20 1.00
DRD2 P14416 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xylometazoline SCHEMBL41837 0.98 HTR1A (1.00) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3300993 0.98 HTR1D (0.97) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3299510 0.98 HTR1D (0.97) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3297417 0.98 HTR1D (0.97) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL871223 0.98 HTR1D (0.97) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL6436975 0.97 HTR1A (0.97) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3301402 0.92 HTR1D (0.84) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3304354 0.92 HTR1D (0.84) HTR1DHTR1BADRA2AADRA2BADRA2C
Xylometazoline SCHEMBL3300203 0.92 HTR1D (0.84) HTR1DHTR1BADRA2AADRA2BADRA2C
SCHEMBL8149986 0.91 HTR1D (1.00) HTR1DHTR1BADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8393 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108531-A1 Methods of Treating Hypogonadism with Transnasal Testosterone Bio-adhesive Gel Formulations in Males with Allergic Rhinitis and Methods for Preventing an Allergic Rhinitis Event ACERUS BIOPHARMA INC (CA) 2026-04-23 US claimed
EP-4724079-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Stealth BioTherapeutics Inc. (US) 2026-04-15 EP claimed
US-12594388-B2 Device to deliver a predetermined amount of a substance to a natural orifice of the body APTARGROUP, INC. (US) 2026-04-07 US claimed
EP-4704839-A2 IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF ALPHERABIO LLC (US) 2026-03-11 EP claimed
US-20260048096-A1 METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS STEALTH BIOTHERAPEUTICS INC. (US) 2026-02-19 US claimed
US-20250255755-A1 WOUND HEALING DEVICE AND METHODS FOR WOUND HEALING SINUS CLEAR INNOVATIONS LLC (US) 2025-08-14 US claimed
EP-4404916-B1 AN IMPROVED PHARMACEUTICAL COMPOSITION FOR NASAL USE, PREPARATION, AND USE THEREOF JADRAN GALENSKI LABORATORIJ D D (HR) 2025-08-06 EP claimed
EP-4596049-A2 PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION Stealth BioTherapeutics Inc. (US) 2025-08-06 EP claimed
US-12377075-B2 Device for internal and external nasal application HALEON CH SARL (CH) 2025-08-05 US claimed
US-20250235641-A1 DEVICE TO DELIVER A PREDETERMINED AMOUNT OF A SUBSTANCE TO A NATURAL ORIFICE OF THE BODY APTARGROUP INC. (US) 2025-07-24 US claimed
US-4741899-A Process for arresting the proliferation of organisms that convert axillary secretions to malodorous materials BRISTOL-MYERS COMPANY (US) 1988-05-03 US claimed
US-4737361-A Alpha adrenergic amine of substantial alpha2 adrenergic amine activity as an antiperspirant BRISTOL-MYERS COMPANY (US) 1988-04-12 US claimed
EP-0086428-B1 ANTIDIARRHOEA VETERINARY COMPOSITION, ITS PRODUCTION AND ORAL DOSER CONTAINING IT BEECHAM GROUP PLC (GB) 1987-07-29 EP claimed
US-4603131-A Method and composition for treating and preventing irritation of the mucous membranes of the nose BERNSTEIN, JOEL E. 1986-07-29 US claimed
EP-0025269-B1 ANTI-DIARRHOEA VETERINARY COMPOSITION BEECHAM GROUP PLC (GB) 1985-11-13 EP claimed
EP-0082546-B1 PHARMACEUTICAL MIXTURE AND METHOD FOR MAKING THE MIXTURE FISONS plc (GB) 1985-08-14 EP claimed
EP-0086428-A1 Antidiarrhoea veterinary composition, its production and oral doser containing it BEECHAM GROUP PLC (GB) 1983-08-24 EP claimed
EP-0082546-A1 Pharmaceutical mixture and method for making the mixture FISONS plc (GB) 1983-06-29 EP claimed
US-4255439-A Means and method for aiding individuals to stop smoking COOPER IRVING 1981-03-10 US claimed
US-3933999-A 1-METHYL-2-(2-(ALPHA-METHYL-P -CHLORODIPHENYLMETHOXY)ETHYL)PYRROLIDONE, RHINITIS, VASOCONSTRICTOR SANDOZ LTD., (SANDOZ AG) (CH) 1976-01-20 US claimed